
Shanti Drugs Private Limited
Manufactures medicinal substances for pharmaceuticals, wholesale and retail chemists, importers and exporters.
Manufactures medicinal substances for pharmaceuticals, wholesale and retail chemists, importers and exporters.
Shanti Drugs Private Limited (SDPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 January 1993 and has a history of 32 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.41 Cr.
The company currently has active open charges totaling ₹3.20 M. The company has closed loans amounting to ₹2.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kamlesh Gupta, Rakesh Gupta, and Om Prakash serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U74899DL1993PTC051735
051735
Private Limited Indian Non-Government Company
15 Jan 1993
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kamlesh Gupta ![]() | Director | 01-Sep-2003 | Current |
Rakesh Gupta ![]() | Director | 15-Jan-1993 | Current |
Om Prakash ![]() | Director | 11-Sep-2020 | Current |
Shanti Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.96% decrease. The company also saw a substantial improvement in profitability, with a 1833.24% increase in profit. The company's net worth moved up by a moderate rise of 2.4%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Shanti Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Kamlesh Gupta is a mutual person
₹0.32 Cr
₹2.20 Cr
Date | Lender | Amount | Status |
---|---|---|---|
12 Sep 2024 | Hdfc Bank Limited | ₹3.20 M | Open |
08 Jun 2010 | Delhi Nagrik Sehkari Bank Ltd. | ₹2.20 Cr | Satisfied |
Shanti Drugs has a workforce of 5 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shanti Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shanti Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shanti Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
A charge with Hdfc Bank Limited amounted to Rs. 0.32 Cr with Charge ID 100995774 was registered on 12 Sep 2024.
Shanti Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Om Prakash was appointed as a Director was appointed as a Director on 11 Sep 2020 & has been associated with this company since 4 years 7 months .
A charge registered on 08 Jun 2010 via Charge ID 10226292 with Delhi Nagrik Sehkari Bank Ltd. was fully satisfied on 05 May 2017.
A charge with Delhi Nagrik Sehkari Bank Ltd. amounted to Rs. 2.20 Cr with Charge ID 10226292 was registered on 08 Jun 2010.
Shanti Drugs Private Limited was incorporated on 15 Jan 1993.
The authorized share capital of Shanti Drugs Private Limited is ₹ 1.50 Cr and paid-up capital is ₹ 1.41 Cr.
Currently 3 directors are associated with Shanti Drugs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Shanti Drugs Private Limited is D-23 Ground Floor South Extn Part-1 India, New Delhi, 110049.
The corporate identification number (CIN) of Shanti Drugs Private Limited is U74899DL1993PTC051735 and the company number is 051735 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Shanti Drugs Private Limited has fallen by -31.96%.
As Per 2023 financial reports, 5 employees are currently employed by Shanti Drugs Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Shanti Drugs Private Limited has experienced an upsurge of 2.40%.
As per the financial statements for fiscal Year 2023, The total open charges for Shanti Drugs Private Limited amount to ₹ 3.20 M.
The most recent Balance Sheet for Shanti Drugs Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.